In 2017, scientists discovered a rare blood group variant found only in parts of East Africa that significantly increases the body’s natural resistance to malaria. It wasn’t until recently, however, that scientists started to understand how this rare blood type, called Dantu, boosts immunity to the disease. By analyzing the blood of 42 healthy children, researchers discovered that Dantu red blood cells are able to stop the Plasmodium falciparum by creating a tighter cell membrane which the parasite is unable to penetrate.

This finding represents another important step in the fight against malaria. Existing tools have not proven sufficient to eradicate the disease. The malaria vaccine, for example, is far from efficient, offering only 35% of protection against the disease. As mosquitoes’ resistance to insecticides and drugs increases, scientific discoveries such as this one, along with the development of new tools, are more topical than ever.

The complete study was published in Nature.

The European Parliament Intergroup on Climate Change, Biodiversity and Sustainable Development will host the webinar “Research and innovation: What role for gene drive?” to support internal EU discussions on the new EU Biodiversity Strategy for 2030, as well as to help define the EU’s position for the CBD COP-15.

Speakers will provide an overview of the technology, the challenges it seeks to solve, and the research projects focused on public health and conservation. The event will also present the work that international and European bodies such as WHO, IUCN and EFSA are carrying out on gene drive.

Are you interested in participating? Register here.

The Convention on Biological Diversity (CBD) recently released the fifth edition of the Global Biodiversity Outlook (GBO-5), a periodic report that summarizes the latest data on biodiversity status and trends. This edition provides an overview of lessons learned over the past two decades, identifying eight necessary changes to meet governments’ commitment to “Living in Harmony with Nature” by 2050.

The report recognizes that none of the Aichi targets on biodiversity will be met in the expected time framework, even though there has been progress in some areas. In the case of invasive alien species (IAS), CBD highlights the advances made in identifying, prioritizing and investigating them, but concludes that there is no evidence of a slowing down in the number of new IAS introductions.

The WHO will release its position statement on genetically modified mosquitoes for vector-borne disease control on October 14, along with its new guidance on ethics and vector-borne diseases. The publications are critical for the prevention and control of diseases such as malaria, as they will guide policymakers and other international organisation’s’ efforts. WHO’s Chief Scientist, Soumya Swaminathan, will host the virtual event, which will also gather other experts from the organisation, University of Oxford, Université Marien Ngouabi (Congo) and more. Register for the virtual event here.

The Convention on Biological Diversity (CBD) recently released the fifth edition of the Global Biodiversity Outlook (GBO-5), a periodic report that summarizes the latest data on biodiversity status and trends. This edition provides an overview of lessons learned over the past two decades, identifying eight necessary changes to meet governments’ commitment to “Living in Harmony with Nature” by 2050.

The report recognizes that none of the Aichi targets on biodiversity will be met in the expected time framework, even though there has been progress in some areas. In the case of invasive alien species (IAS), CBD highlights the advances made in identifying, prioritizing and investigating them, but concludes that there is no evidence of a slowing down in the number of new IAS introductions.